AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,552,000 | -26.6% | 120,230 | +18.1% | 3.86% | -23.3% |
| Q1 2019 | $4,837,000 | +20.2% | 101,811 | -8.7% | 5.02% | +6.3% |
| Q4 2018 | $4,024,000 | -26.4% | 111,501 | +25.6% | 4.73% | +8.7% |
| Q3 2018 | $5,465,000 | +17.8% | 88,797 | +29.3% | 4.35% | +18.5% |
| Q2 2018 | $4,638,000 | +247.4% | 68,666 | +179.2% | 3.67% | +264.9% |
| Q1 2018 | $1,335,000 | -77.3% | 24,597 | -75.0% | 1.01% | -74.2% |
| Q4 2017 | $5,877,000 | – | 98,350 | – | 3.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |